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Tryptophan metabolites anthranilic acid (AA) and 3-hydroxyanthranilic acid     
(3-OHAA) have been implicated in the etiology of bladder cancer. Metal-mediated 
activation of these compounds into mutagens was tested using a plasmid relaxation assay 
at increasing concentrations of copper (Cu (II)) at 5 µM-20 µM in the presence of 
plasmid pSP-72. One hundred µM 3-OHAA induced plasmid relaxation in the presence 
of metal cofactor Cu (II) at a concentration as low as 5 µM. The Cu (II) mediated 
mutagenic activation of 3-OHAA was further investigated using Ames 
Salmonella/microsome mutagenicity assay with the reactive oxygen species 
(ROS) sensitive tester strain Salmonella TA102. A significant increase in TA102 
revertants was observed with an increase in concentration of Cu (II) from 2.5 µg to 50 µg 
incubated with 100 µg 3-OHAA/plate but not AA.  This evidence for mutagenicity with 
only 3-OHAA in the presence of Cu (II) but not with AA suggests that the presence of 
the hydroxyl group in 3-OHAA is critical for generating ROS mediated mutagenicity. In 
summary, this study finds that 3-OHAA, in the presence of the metal cofactor copper 








This manuscript was written and intended to be submitted for publication in the 
journal Environmental and Molecular Mutagenesis. Additionally, two sections that 
include the introduction explaining the rationale behind this work and conclusion 
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Bladder cancer is ranked as the ninth most prominent cause of cancer and ranked 
thirteenth in number of deaths caused by cancer [Parkin, 2008]. Harvard Men’s health 
Watch [2011] reported that in The USA bladder cancer is more prevalent in men than 
women. It is ranked as the fourth most common cause of cancer among men. Various 
factors that include cigarette smoking, occupational exposure to industrial aromatic 
amines, and dietary factors are attributed to the cause of bladder cancer [Gazdar, 2001; 
Pelucchi et al., 2006]. Pavanello et al. [2007] reported that the urine collected from the 
urinary bladder of non-smokers after overnight retention displayed mutagenic activity. 
They have attributed that the cause to the consumption of diet with high mutagenic 
content and accumulation of mutagenic metabolites in their urine.  
Benassi et al. [1963] reported that there was an increase in the excretion of 
tryptophan metabolites in patients suffering from bladder cancer and urological diseases. 
Teulings et al. [1978] reported that bladder cancer patients have excreted particularly 
high concentrations of 3-hydroxyanthranilic acid (3-OHAA) and 3-hydroxykynurenine 
(3-OHKN) excreted in their urine. Kerr et al. [1964] noticed an interesting structural 
similarity of 3-OHAA and 3-OHKN with a known bladder carcinogen 2-naphthylamine. 
They have both amino and hydroxyl groups at the ortho position to each other, and hence 
classified as ortho-amino phenols. Bryan et al. [1971] reported that cholesterol implants 
of 3-OHAA, 3-OHKN, and anthranilic acid (AA) in the urinary bladders of mice caused 
bladder tumors. Teulings et al. [1975] reported that untreated bladder and kidney 
carcinoma patients excreted high amounts of unconjugated 3-OHAA in their urine when 
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compared to the healthy individuals. Several other reports from animal models suspected 
the role of the tryptophan metabolites as a cause of bladder cancer have been reviewed by 
Chung and Gadupudi [2011].  
Kawanishi et al. [2002] proposed that the metal cofactors such as the iron (Fe 
(II)), copper (Cu (II)), and manganese (Mn (III)) present in the human body would 
interact with various metabolites generated from xenobiotic compounds or endogenous 
compounds, produce reactive oxygen species (ROS) and cause mutagenesis. Fe (II) in the 
presence of a tryptophan metabolite serotonin was reported to cause DNA damage by 
generating hydroxyl radicals (OH-) [Hadi et al., 2002]. Cu (II) in the presence of L-Dopa, 
a precursor of dopamine, caused DNA adducts in the brain tissue [Spencer et al., 1994]. 
Recently, Mazdak et al. [2011] reported increased copper concentration in the serum of 
bladder cancer patients.  
Because of the above reports, the current study demonstrates the ability of 
tryptophan metabolites AA and 3-OHAA to cause mutagenesis. We also evaluated the 
role of metal cofactors, particularly Cu (II), in activating the tryptophan metabolites AA 
and 3-OHAA to mutagens in vitro. The possibility of rat liver S9 fraction would detoxify 










Evidence for Genotoxicity of 3-Hydroxyanthranilic Acid but not Anthranilic Acid in 
the Presence of a Metal Cofactor Cu (II) In Vitro 
Introduction 
Tryptophan is an essential amino acid and a precursor for many metabolites 
including serotonin, nicotinamide adenosine dinucleotide (NAD), niacin, and indole 
acetic acid [Krehl et al., 1945]. The metabolism of tryptophan occurs in the liver and 
generates many intermediate metabolites that are involved in liver and bladder 
carcinogenesis [Sidransky H, 1997]. Tryptophan is metabolized mainly in three 
pathways: serotonin, indole, and kynurenine or NAD pathways. Metabolites anthranilic 
acid (AA), 3-hydroxyanthranilic acid (3-OHAA), kynurenine (KN), 3-
hydroxykynurenine (3-OHKN) generated during NAD synthesis are localized in the liver, 
kidney, bladder and are implicated in playing a role in bladder and kidney tumorigenesis. 
Recently, a comprehensive review on tryptophan metabolism and its metabolites in 
causing bladder tumorigenesis was described by Chung and Gadupudi [2011].  
The 3-OHAA is synthesized in the NAD pathway from its precursor 3-OHKN or 
KN by kynureninase (L-KN hydrolase, EC 3.7.1.3) in the presence of cofactor vitamin 
B6 [Bertazzo et al., 2001; Chung and Gadupudi, 2011]. It has been indicated by clinical 
studies that bladder cancer patients secreted a significant increase in basal concentration 
of the 3-OHAA in their urine compared to healthy individuals [Teulings et al., 1973; 
Teulings et al., 1975]. Another study of ten bladder cancer patients by Boyland and 
Williams [1956] reported an increase in excretion of 3-OHAA, AA along with other 
tryptophan metabolites KN, and 3-OHKN in their urine. 3-OHAA when implanted in 
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mouse bladders on a cholesterol vehicle induced bladder tumors [Allen et al., 1957]. 
Watanabe et al. [1979] proposed that individual differences in excretion ratio of 3-OHAA 
could play a role in the etiology of bladder cancer. Clayson et al. [1958] proposed that 
aromatic amines with the hydroxyl group at ortho positon are carcinogenic. These 
compounds with both amino and hydroxyl group at ortho postion to each other are called 
ortho-aminophenols. The 3-OHAA and 3-OHKN are endogenous ortho-aminophenols 
generated in the NAD pathway and excreted in increased amounts by bladder cancer 
patients. Additionally, they are also similar in structure to other known bladder 
carcinogens like 2-naphthylamine; however the mechanisms involved in causing 
carcinogenesis are unknown [Kerr et al., 1965]. Many enzymes in tryptophan metabolism 
require vitamin B6 as a cofactor including kynureninase described above for generating 
3-OHAA. A deficiency in vitamin B6 would stop further metabolism and accumulate 
these metabolites in the bladder and possibly cause carcinogenesis [Kerr et al., 1965; Birt 
et al., 1987; Rose DP 1972].  
Several endogenous metabolites generated from xenobiotic aromatic 
hydrocarbons and biological compounds are able to induce a co-mutagenic effect in the 
presence of physiologically available metal cofactors like Mn (III), Cu (II), Zn (II), Fe 
(II), by generating reactive oxygen species (ROS) [Kawanishi et al., 2002; Chung and 
Gadupudi, 2011; Ando et al., 2011]. Iwahashi et al. [1988] proposed that 3-OHAA in the 
presence of Fe (III) is oxidized to generate anthranilyl radical, which later condenses into 
cinnabarinic acid that eventually forms DNA adducts. Apparently, reduction of Fe (III) to 
Fe (II) by the anthranilyl radical generates fenton chemistry to cause hydroxyl radical 
mediated cell damage [Dykens et al., 1987]. The byproduct cinnabarinic acid was also 
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reported to cause apoptosis in thymocytes by generating ROS [Hiramatsu et al., 2008]. 
Another important cofactor Cu (II) is also believed to play a crucial role in the oxidative 
stress. Salsolinol, a neurotoxin, in the presence of Cu (II) induced DNA strand breaks in 
the calf thymus DNA and caused cell death in PC12 cells by causing oxidative stress 
[Kim et al., 1997]. Similarly, L-Dopa, a precursor of dopamine, in the presence of Cu (II) 
was able to cause DNA damage in vitro [Husain and Hadi, 1995]. 5-Hydroxytryptamine 
in the serotonin pathway was also showed to cause DNA cleavage in vitro possibly by 
generating hydroxyl radicals [Hadi et al., 2002]. Aminoacetone and 3-OHAA metabolites 
of threonine and tryptophan, respectively in the presence of Cu (II), caused DNA damage 
in protoncogene c-Ha-ras-1 [Hiraku et al., 1995; Hiraku et al., 1999]. 
In the present study, we have evaluated the ability of tryptophan metabolites 3-
OHAA, AA in the presence metal cofactor Cu (II) to cause mutagenesis. Salmonella 
strain TA102 sensitive to oxidative mutagens was employed to check their potency to 
cause oxidative stress inside the cell. DNA scission studies were observed by the plasmid 
relaxation assay. Studies on physiological metabolic activation of 3-OHAA and AA in 
the presence of copper were mimicked by using rat liver S9 fraction.        
Materials and Methods 
Reagents 
All the chemicals AA, 3-OHAA, 4-Aminobiphenyl (4-Ab), dimethylsulfoxide 
(DMSO), hydrogenperoxide (H2O2), nicotinamide adenine dinucleotide phosphate 
monosodium salt (NADP), glucose-6-phosphate, mitomycin C (MMC), 
ethelenediamintetraacetate (EDTA), ferrous sulphate (FeSO4), copper sulphate (CuSO4), 
zinc sulphate (ZnSO4) and manganese chloride (MnCl3) were purchased from Sigma (St. 
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Louis, MO). AA, 3-OHAA and MMC solutions were freshly dissolved in DMSO. FeSO4, 
CuSO4, ZnSO4, MnCl3 solutions were made with distilled water. Oxoid nutrient broth no. 
2 for culturing Salmonella typhimurium TA102 was obtained from BD Biosciences 
(Sparks, MD).  The Aroclor 1254-induced rat liver post mitochondrial supernatant S9 in 
0.154 M KCl was purchased from Molecular Toxicolgy Inc. (Boone, NC).      
Bacterial cultures and plasmids 
Tester strain Salmonella typhimurium TA102 (TA102) was purchased from 
Molecular Toxicology Inc. (Boone, NC). Stocks were prepared from overnight cultures 
(12-13 hrs) grown in Oxoid broth no. 2 at 370 C. One ml aliquots of stock cultures were 
prepared by adding DMSO as a cryoprotective agent to an overnight culture of TA102. 
All the aliquots were snap-freezed on dry ice and stored at -80o C.  The tester strain 
TA102 was regularly monitored for phenotypic variations and viability as described in 
Mortelmens et al. [2000].  The Plasmid PSP-72 used in the plasmid relaxation assay was 
provided by Dr. Carlos Estraño, The University of Memphis.  
Plasmid relaxation assay 
All the metabolites were screened for mutagenic abilities using plasmid relaxation 
assay as described in Falcioni et al., 2002. 100 ng of plasmid pSP-72 was incubated in 
100 mM sodium phosphate buffer at pH 7.4 along with the test chemicals AA or 3-
OHAA at concentrations 50 µM, 100 µM, 150 µM, 200 µM and 400 µM. The respective 
test chemical concentrations were also incubated with metal cofactors Fe (II), Cu (II), and 
Mn (III) at concentrations 2.5 µM, 5µM, 10 µM, 15 µM, and 20 µM while checking for 
metal mediated plasmid relaxation. The reaction mixture containing the chemical, metal 
cofactor, plasmid and buffer were incubated in the dark at 370C for 2 hrs. After 2 hrs, the 
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reaction volume was mixed with 5 µl gel loading buffer and was loaded onto 0.7 % 
agarose gel and electrophoresed at 80V for 1hr. The gels were loaded with plasmid DNA 
in DMSO alone on the first well as a negative control. The second well was loaded with 
plasmid DNA along with Fe (II) as the positive control [Flemmig and Arnhold, 2007]. 
The third well was generally loaded with test chemical without any metal cofactor along 
with DNA. The rest of the wells 4th – 8th were loaded in the increasing order of the metal 
cofactor (2.5 µM, 5µM, 10 µM, 15 µM, and 20 µM) and 100 µM test chemical  or 
increasing order of the test chemical (50 µM , 100 µM, 150 µM, 200 µM and 400 µM) 
and 10 µM of metal cofactor along with DNA. The results were pictured using BIO-RAD 
gel documentation system and analyzed using BIO-RAD Chemi-doc software (Bio-Rad 
laboratories, Inc, USA). 
Ames Salmonella/microsome mutagenicity assay  
The Ames Salmonella mutagenicity assay was performed according to the pre-
incubation protocol described by Maron and Ames, [1983]. The test samples that required 
metabolic activation were incubated with Aroclor 1254-induced rat liver post 
mitochondrial supernatant S9 as suggested in Mortelmans et al. [2000]. 50 µl of viable 
TA102 was inoculated into 50 ml of Oxoid broth No.2 (25 gm in one L of distilled water) 
and grown at 37 0 C on incubator-shaker at 160 RPM. The culture was grown for 12- 16 
hrs until the required cell density of 1-2 x 109 cfu/ml was reached. The S9 mix required 
for metabolic activation was freshly prepared by mixing one ml Aroclor 1254-induced rat 
liver post mitochondrial supernatant S9 in 0.154 M KCl in nine ml of the S9 Cofactor 
buffer (10% v/v) and filter sterilized through a 0.45 µm filter membrane.  The freshly 
prepared cofactor buffer contains 0.5 mM glucose-6-phosphate, 0.4 mM NADP, 0.8 mM 
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MgCl2, 3.3 mM KCl, and 10 mM sodium phosphate at pH 7.4. Sterile glass tubes that 
contained the reaction mixture, which include 500 µl 0.1M sodium phosphate buffer (pH 
7.4) or the S9 mix, 50 µl of the test chemical solution, 50 µl of metal cofactor (CuSO4) 
and 100 µl of TA102 were incubated at 370 C at 160 RPM on a shaker for 45 min. The 
reaction mixture was then mixed with 2 ml of molten soft agar (6 g/L agar and 6 g/L 
NaCl) with histidine (0.5 mM) at 480 C, vortexed and  quickly spread uniformly on a 
minimal glucose agar plate (GM agar plate). The plates were incubated at 370 C for 48 
hrs and the numbers of revertants were counted on a colony counter. The test chemicals 
AA, 3-OHAA, when tested alone were tested at concentrations of 5 µg through 250 µg (5 
µg, 10 µg, 50 µg, 100 µg and 250 µg).  The assay was performed at fixed concentrations 
of 100 µg AA or 3-OHAA per plate when tested for metal mediated activation. The 
concentrations of the Cu (II) were varied from 2.5 µg though 100 µg per plate (2.5 µg, 5 
µg, 10 µg, 20 µg, 50 µg, 100 µg). The recommended positive control MMC for TA102 
was used at a concentration of 0.5 µg per plate. 4-Aminobiphenyl was used as a positive 
control for the metabolic activation in the presence of S9 mix. DMSO was used as a 
negative control.  
Statistical analysis 
Each experiment was performed with three replicates (3 plates) for a particular 
concentration or a given particular chemical. The statistical significance was calculated 
by one way analysis of variance (ANOVA) using the program Graph pad prism. The 






3-OHAA in the presence of Cu (II) induces DNA strand nicks in DNA 
It has been reported that Fe (II) in the presence of serotonin causes DNA damage 
by single stranded nicks [Hadi et al., 2001]. Previous studies in our lab have also 
demonstrated that Fe (II) in the presence of benzidine (Bz) and 4-Ab was able to induce 
DNA damage by causing nicks in a supercoiled plasmid (Makena and Chung unpublished 
results).  Spencer et al.  [1994] reported that copper in the presence of L-dopa forms 
DNA adducts.  We have attempted here to demonstrate the metal mediated toxicity of 3-
OHAA. Cu (II) at increasing doses from 2.5 µM – 20 µM were incubated with 100 µM 3-
OHAA. We determined whether they caused DNA strand breaks in the supercoiled 
plasmid pSP-72 (Fig 1). A nick in the supercoiled form of plasmid changed its 
electrophoretic mobility and two bands of plasmid DNA could be observed if the test 
chemical induced nicks in the plasmid. DMSO as a negative control did not show any 
nicked form of the DNA (lane 1), and Fe (II) at 10 µM that showed a clear lag mobility 
of the band was used as a positive control (lane 2). Five µM Cu (II) in presence of 3-
OHAA was able to induce nicks in the plasmid DNA; however, the nicked plasmid was 
not clearly visible (lane 5). Copper at increased concentrations of 10 µM (lane 6), 15 µM 
(lane 7), 20 µM (lane 8) in the presence of a 3-OHAA dose dependently increased the 
amount of plasmid pSP-72 being nicked to the circular form and hence clearly showed an 
receding band due to the slow mobility of the plasmid (Fig 1). The 3-OHAA at 100 µM 
alone did not cause any change in position of the band (lane 3).  
In order to understand the minimum concentration of 3-OHAA necessary for 
causing the DNA damage in vitro, Cu (II) at 10 µM was incubated with increasing 
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concentrations of 3-OHAA from 50 µM – 400 µM and observed for band shift (Fig. 2.). 
50 µM of 3-OHAA in the presence of 10µM Cu (II) was able to cause a nick in the 
plasmid; however all supercoiled DNA was not turned into circular plasmid (lane 4). An 
increase in the concentration of 3-OHAA to 100 µM (lane 5), one hundred and fifty µM 
(lane 6), 200 µM (lane 7) and 400 µM (lane 8) caused an apparent band shift by 
converting almost all the supercoiled pSP-72 to circular nicked forms. The pSP-72 
incubated with 10 µM Cu (II) alone did not show any DNA strand breaks (lane 3). An 
increase in the Cu (II) concentration alone on pSP-72 from 1 µM though 20 µM also did 
not show any DNA strand breaks, suggesting that Cu (II) alone cannot cause DNA 
damage in vitro (Fig 3).  
In contrast to 3-OHAA, AA in the presence of Cu (II) did not show any DNA 
strand breaks in pSP-72 (Fig 4). These results suggest that Cu (II) at a concentration of 10 
µM in the presence of 100 µM of 3-OHAA can induce DNA strand break in vitro. 
3-OHAA and AA alone were not mutagenic to Salmonella TA102 with or without 
activation by S9  
Bowden et al. [1976] have tested the mutagenic effect of tryptophan metabolites 
AA, 3-OHAA and other compounds with Salmonella tester strains TA1535, TA1537, 
TA1538, TA98, TA100, but not TA102 and reported no significant mutagenic effect in 
the presence or absence of S9. However, it was reported that AA and 3-OHAA were co-
mutagenic in the presence of 2-aminoanthracene (2-AA) and S9 treatment. In the present 
study, TA102 was employed in the Ames Salmonella/microsome mutagenicity assay to 
evaluate the mutagenic effect of AA and 3-OHAA with and without S9 (Fig. 5 and 6). It 
is important to test the mutagenic effects with TA102, because it is sensitive to oxidative 
11 
 
mutagens; whereas, other strains are not particularly sensitive to them [Levin et al., 
1982]. Both AA and 3-OHAA were incubated with TA102 (at five concentrations of 5 
µg, 10 µg, 50 µg, 100 µg, 250 µg/per plate) did not show any significant increase in 
revertants when compared with the negative control DMSO (Fig. 5). MMC at 0.5 µg was 
used as a positive control.  
 Anthranilic acid and 3-OHAA were also treated with aroclor induced rat liver S9 
metabolic activation system, in the presence of NADP (S9 mix), at the concentrations 5 
µg - 250 µg to test for production of oxidative mutagenic intermediates or radicals. No 
significant difference in number of revertants was observed with reference to negative 
control DMSO when treated with S9 mix (Fig. 6). We have used 4-Ab as a positive 
control for metabolic activation of a test chemical in the presence of rat liver S9 mix as 
previously reported from our lab [Makena and Chung, 2007]. 
3-OHAA in the presence of Cu (II) and absence of S9 was mutagenic to Salmonella 
TA102 
Previous studies in our lab suggest that the metal cofactor Fe (II) activates 
benzidine and 4-Ab to cause a mutagenic effect on TA102. Hiramatsu et al. [2008] 
reported that MnCl2 in the presence of 3-OHAA was able to induce apoptosis of cells by 
generating reactive oxygen species (ROS). Serotonin was reported to interact with Cu (II) 
in the cytosol to generate hydroxyl radicals. These hydroxyl radicals were generated by 
the oxidation of phenolic group of serotonin [Hadi et al., 2002]. In the present study AA 
and 3-OHAA at a concentration of 100 µg per plate were treated at six concentrations of 
Cu (II) at 2.5 µg, 5 µg, 10 µg, 20 µg, 50 µg, 100 µg and incubated along with Salmonella 
TA102. The 3-OHAA significantly increased the number of revertants per plate when 
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treated at increasing concentrations of Cu (II) (Fig. 7). One hundred µg of 3-OHAA was 
able to induce significant mutagenic effect at Cu (II) concentration as low as 5 µg (P < 
0.05). An increase in the concentration of Cu (II) showed a significant dose response in 
causing mutagenesis (Fig. 7). In contrast, AA in the presence of Cu (II) (at all 
concentrations) did not induce any significant increase in the number of revertants per 
plate compared to the negative control DMSO (Fig. 8).  TA102 was also incubated with 
only Cu (II) alone at all concentrations without AA or 3-OHAA to test whether Cu (II) 
alone was able to induce any mutagenic effect. Cu (II) was unable to induce mutagenic 
effect at all concentrations tested on TA102 (white plain bars in Fig. 7 and 8). Also, AA 
and 3-OHAA at 100 µg were unable to induce mutagenic effect by themselves on TA102. 
Mitomycin C at 0.5 µg was used as a positive control.  Figure 9, shows a comparison of 
mutagenic effect of AA and 3-OHAA on TA102.     
3-OHAA in the presence of Cu (II) and S9 mix was not mutagenic to TA102 
To check for physiological metabolic activation in the presence of Cu (II), both 
AA and 3-OHAA were incubated with 5 µg, 20 µg, 100 µg of Cu (II) and S9. There was 
no significant difference in the number of revertants per plate when both AA and 3-
OHAA were treated with S9 mix in the presence of Cu (II) (Fig. 10). 3-OHAA, which 
was able to cause mutagenic effect without S9 (Fig. 9), was unable to show any 
significant mutagenic effect in the presence of S9 (Fig. 10).  
This demonstrates that the rat liver S9 might inhibit the oxidative stress induced by Cu 






Dietary compounds like food additives, cooked products of meat and fish, 
phytoestrogens in plants, amino acids and their metabolites are implicated to induce 
carcinogenesis by generating reactive oxygen species (ROS) [Ames BN, 1983; Klaunig et 
al., 2011]. Bryan et al. [1964a-b] reported that tryptophan metabolites 3-OHAA and 3-
OHKN implanted in a cholesterol vehicle significantly induced bladder tumors in mice. 
Fe (II) and Cu (II) interacting with serotonin, a tryptophan metabolite, induce DNA 
cleavage [Hadi, 2002]. Tryptophan metabolism is associated with generation of 
intermediate metabolite quinolinic acid which is neurotoxic.  Quinolinic acid in the 
presence of 2 µM Fe (II) concentration was able to induce lipid peroxidation in brain 
homogenates of mice [Stipek et al., 1997; Johnson S, 2001]. Several studies have 
reported that metal cofactor mediated toxicity of tryptophan metabolites in the serotonin 
pathway but not nicotinamide pathway. In contrast to the toxicity caused by metabolites 
in the serotonin pathway to brain tissue, metabolites in the nicotinamide pathway 
including AA, 3-OHAA, 3-OHKN, KN might cause problems with liver, kidney and 
bladder. In the present study, the electrophoresis data indicates that 100 µM of 3-OHAA 
in the presence of Cu (II) concentration as low as 5 µM was able to induce DNA strand 
breaks in the pSP-72 plasmid, whereas AA did not cause any effect. 
L-DOPA (L-3,4-dihydroxyphenylalanine), an endogenous metabolite generated in 
the dopamine synthesis, caused mutagenesis in the presence of Cu (II). Short lived OH- 
radicals were generated through reduction of Cu (II) to Cu (I) in the presence of L-DOPA 
which caused strand scission of DNA [Husain and Hadi, 1995]. Hiraku et al. [1999] 
reported that aminoacetone generated during the threnonine and glycine metabolism 
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interacted with Cu (II) to produce free hydroxyl radicals and damaged DNA at cytosine 
and thymine residues. Alternatively, 3-OHAA could also be auto oxidized in the presence 
of oxygen to generate 3-OHAA radical (anthranilyl radical), which is further oxidized to 
quinonemine. Consequently, quinonemine is condensed along with another 3-OHAA 
molecule in the presence of oxygen to generate cinnabarinic acid and hydrogen peroxide 
[Dykens et al., 1987]. In the present study, Ames test data with Salmonella TA102 
suggest that 3-OHAA is significantly mutagenic only in the presence of Cu (II) at 
quantity as low as 5 µg/per plate. However, AA in the presence or absence of copper did 
not result in any mutagenesis. It should be noted here that TA102 is an oxidative stress-
sensitive strain, and significant increase in its revertants is associated with oxidative 
stress caused by test chemical 3-OHAA.  Previous results from Bowden et al. [1976] had 
no mutagenic effect because they used other Salmonella tester strains which were not 
sensitive to ROS. In the present studies with TA102, 3-OHAA in presence of Cu (II), 
causes mutagenesis in vitro by generating oxidative stress. Structurally, both AA and 3-
OHAA are almost similar except for the presence of an extra hydroxyl group at the ortho 
position to amino group in 3-OHAA. The oxidative mutagenic effects of only 3-OHAA 
in the presence of Cu (II) could be attributed to the functionality of this extra hydroxyl in 
3-OHAA. 
Physiologically, environmental contaminants are bioactivated either in the liver or 
sometimes by resident bacteria in the intestines [Chung et al., 1975a-b]. Benzidine and 4-
Ab were metabolically activated by rat liver S9 mix (in the presence of NADP) to 
mutagens by generating ROS [Makena and Chung, 2007]. Adris and Chung [2006] have 
previously demonstrated that the bacterium Pseudomonas aeroginosa was able to activate 
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2-aminoflourene, 4-Ab and benzidine to carcinogens. 3-OHAA and AA in presence rat 
liver S9 mix alone were not mutagenic in Salmonella TA102 and hence they both are not 
metabolically activated without the presence of metal cofactor Cu (II). However, it was 
also observed here that the significant mutagenic effect of Cu (II) and 3-OHAA in TA102 
without S9 mix discussed above was blunted when treated with S9 mix (reduction in the 
number of revertants) in vitro. From the above results it could be interpreted that the toxic 
effect of 3-OHAA and Cu (II) in liver could possibly be detoxified by the liver. However, 
their presence in other tissues like kidney and bladder may apparently lead to 
mutagenesis. 
Lai et al. [2010] reported a significantly high increase in hepatic concentrations of 
copper (40 % to control) in Sprague-Dawley rats when exposed to industrial toxicant 3, 
3’, 4, 4’, 5-pentachlorobiphenyl (PCB 126). A similar study where Sprague-Dawley rats 
were exposed to the environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
reported a 2-fold and 4-hold Cu (II) ion concentration increase in the liver and kidney 
respectively [Elsenhans et al., 1991]. It was suggested that under excessive intake of 
copper or circumstances of liver damage, excess Cu (II) is excreted by the kidneys into 
the urinary bladder [Mahoney et al., 1955]. Teulings et al. [1978] reported that an 
increased excretion of tryptophan metabolites, especially 3-OHAA and 3-OHKN 
occurred in bladder and renal cancer patients. Several other animal studies have also 
demonstrated involvement of tryptophan metabolites in bladder cancer; however, the 
mechanism involved in carcinogenesis was not specified. Recently, Mazdak et al. [2010] 
measured the serum concentrations of trace metal cofactors Cu (II), Zn (II), and Fe (II) in 
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the bladder cancer patients and reported a significant increase in Cu (II) levels compared 
to healthy individuals (P<0.001).  
In agreement with the above reports, our results indicate interaction of both Cu 
(II) and 3-OHAA during urinary excretion could generate oxidative stress that probably 
plays a role in causing mutagenesis in bladder epithelial cells leading to bladder 
carcinogenesis. Further in vivo research to evaluate the role of the metal cofactor Cu (II) 
and the tryptophan metabolite 3-OHAA in causing bladder cancer is needed in support of 










The hypothesis for this work was based on several epidemiological studies that 
reported an increased excretion of the tryptophan metabolites, especially anthranilic acid 
(AA), 3-hydroxyanthanilic acid (3-OHAA), 3-hydroxykynurenine, and kynurenine in the 
urine of bladder cancer patients [Teulings et al., 1978; Rose, 1972; Sidransky, 1997]. In 
the current study, we evaluated two of these metabolites, anthranilic acid (AA), and 3-
hydroxyanthanilic acid (3-OHAA), for their mutagenic potential. This study also 
demonstrates the effect of a metal cofactor particularly the copper (Cu (II)) on these 
metabolites to cause mutagenesis. 
Initially, the plasmid relaxation assay was employed using pSP-72 to observe 
whether these compounds have the ability to cause any DNA damage. It was found that 
both of the metabolites were unable to cause any DNA nicks in the supercoiled plasmid. 
Subsequently, when these metabolites were incubated with the metal cofactor Cu (II), 3-
OHAA was able to cause DNA damage whereas Cu (II) with AA was unable to cause 
DNA damage. 
Further study, to understand the mechanism involved in the DNA damage was 
performed using Ames Salmonella/microsome mutagenicity assay. Among the various 
tester strains, a relatively new tester strain Salmonella TA102, sensitive to the oxidative 
mutagens, was used in this assay to understand the underlying mechanism [Levin et al., 
1982]. TA102, used in this study, was not sensitive to both AA and 3-OHAA when 
incubated alone. However, it was significantly sensitive to 3-OHAA in the presence of 
metal cofactor Cu (II). Alternatively, there was no significant TA102 sensitivity in the 
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presence of Cu (II) and AA. It was previously reported by Bowden et al. [1976] that both 
AA and 3-OHAA were not mutagenic when tested with other strains TA1538, TA98, 
TA100. These distinct results in the present study were attributed to the sensitivity of 
TA102 to oxidative stress; whereas, the previous strains were insensitive. The results 
thereby implicate that 3-OHAA in the presence of metal cofactor Cu (II) causes oxidative 
stress-induced mutagenicity. 
Consequently, to demonstrate physiological relevance, the mixtures of Cu (II) and 
compound (AA and 3-OHAA) were treated with rat liver S9 (S9) to check the 
detoxification ability of the liver. It was observed that, in the presence of S9, the 
demonstrated mutagenic effect by Cu (II) and 3-OHAA was nullified. Although these 
results imply that the liver detoxifies the oxidative stress, it is also important to note that 
3-OHAA is not only localized in liver, but present in various other organs like the bladder 
and kidney which do not have any detoxifying enzymes [Watanabe, 1978].  
In summary, this study finds that 3-OHAA, in the presence of the metal cofactor copper 
causes oxidative stress that damages DNA. This signifies that the accumulation of excess 
3-OHAA and Cu (II) in the urinary bladder [Mahoney et al., 1955] might lead to 
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Fig.  1. Plasmid relaxation assay of Cu (II) and 3-hydroxyanthranilic acid (3-OHAA) 
with change in concentrations of Cu (II). Plasmid pSP-72 was incubated with 100 µM 3-
OHAA at various concentrations of Cu (II) (2.5 µM – 20 µM). Lane 1 is a negative 
control with DMSO, lane 2 is positive control with 10 µM Fe (II) and lane 3 is 100 µM 3- 
OHAA only. Lanes 4-8 show effect of varying concentration of Cu (II) at 2.5 µM, 5 µM, 





Fig.  2. Plasmid relaxation assay of Cu (II) and 3-hydroxyanthranilic acid (3-OHAA) with 
change in concentration of 3-OHAA. Plasmid pSP-72 was incubated with 10 µM Cu (II) 
at various concentrations of 3-OHAA (50 µM – 400 µM). Lane 1 is a negative control 
with DMSO, lane 2 is positive control with 10 µM Fe (II) and lane 3 is 10 µM Cu (II) 
only. Lanes 4-8 show effect of varying concentration of 3-OHAA at 50 µM, 100 µM, 150 








Fig.  3. Plasmid relaxation assay at various concentrations Cu (II) only. Lane 1 is a 
negative control with DMSO, lane 2 is a positive control with 10 µM Fe (II). Lanes 3-8 
show effects of varying concentrations of Cu (II) at 1 µM, 2.5 µM, 5 µM, 10 µM, 15 µM 













Fig.  4. Plasmid relaxation assay of anthranilic acid (AA) and 3-hydroxyanthranilic acid 
(3-OHAA) in the presence of Cu (II). Lanes 1-6 show the effect of 100 µM AA at various 
concentrations of Cu (II) (1 µM – 20 µM) on pSP-72. Lane 7 is pSP-72 with 100 µM of 
AA only. Lane 8 is pSP-72 only.  Lane 9 is the positive control 10 µM Fe (II) in presence 
of pSP-72.  Lane 10 is pSP-72 with DMSO as negative control. Lane 11 is 3-OHAA only 
with pSP-72. Lanes 12 -17 show the effect of 100 µM 3-OHAA at various concentrations 




































































Fig.  5. The mutagenic effect of anthranilic acid (AA) and 3-hydroxyanthranilic acid (3-
OHAA) without any S9 metabolic activation on ROS sensitive TA102. DMSO is the 
negative control and MMC is the positive control. (***) indicates P<0.001 with reference 
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Fig.  6. The mutagenic effect of anthranilic acid (AA) and 3-hydroxyanthranilic acid (3-
OHAA) with S9 metabolic activation on ROS sensitive Salmonella TA102. DMSO is the 
negative control and 4-Ab is the positive control. (***) indicates P<0.001 with reference 
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Fig. 7.  The mutagenic effect of 3-hydroxyanthranilic acid (3-OHAA) in presence of     
Cu (II) without any metabolic activation, on ROS sensitive Salmonella TA102. DMSO is 
the negative control and MMC is the positive control. (***) indicates P<0.001 with 
reference to the negative control DMSO. (*) and (**) indicate P<0.05 and P<0.01 
respectively with reference to the negative control DMSO. (#) indicates P<0.001 with 
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Fig. 8. The mutagenic effect of anthranilic acid (AA) in presence of Cu (II) without any 
metabolic activation on ROS sensitive Salmonella TA102. DMSO is the negative control 
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Fig. 9. Comparative mutagenic effects of 3-hydroxyanthranilic acid (3-OHAA) and 
anthranilic acid (AA) in the presence of Cu (II) without any metabolic activation on ROS 
sensitive Salmonella TA102. DMSO is the negative control and MMC is the positive 
control. (***) indicates P<0.001 with reference to the negative control DMSO. (*) and 
(**) indicate P<0.05 and P<0.01 respectively with reference to the negative control 
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Fig. 10. Comparative mutagenic effects of 3-hydroxyanthranilic acid (3-OHAA) and 
anthranilic acid (AA) in the presence of Cu (II) with S9 metabolic activation on ROS 
sensitive TA102. DMSO is the negative control and 4-Ab is the positive control. (***) 
indicates P<0.001 with reference to the negative control DMSO.  
 
